<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30251277</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1600-0560</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>24</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of cutaneous pathology</Title>                <ISOAbbreviation>J. Cutan. Pathol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Post-radiation vascular lesions of the breast.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1111/cup.13363</ELocationID>            <Abstract>                <AbstractText>Post-radiation vascular lesions are a rare complication most commonly seen in patients previously treated for breast cancer. The main two entities include angiosarcoma (AS), which are malignant tumors that have a poor prognosis, and atypical vascular lesions (AVL), which typically behave in a benign manner and only rarely progress to angiosarcoma. The overall incidence of these lesions is low, but it appears to be increasing. Histopathologic distinction of AVL and AS is essential due to different clinical outcomes and treatment. However, due to the occasional existence of overlapping clinical and histopathologic features, it may be sometimes difficult to render a definite diagnosis, particularly in small biopsies. Ancillary techniques are, in general, of little help for separating the borderland cases but, in some instances, immunohistochemical study (IHC) for Ki67 and IHC or fluorescence in situ hybridization analysis for MYC may help in the diagnosis of angiosarcoma. Herein we discuss the clinical characteristics, histopathologic features, management strategies, and outcome of these lesions, with special emphasis on their differential diagnosis.</AbstractText>                <CopyrightInformation>Â© 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ronen</LastName>                    <ForeName>Shira</ForeName>                    <Initials>S</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8967-2257</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ivan</LastName>                    <ForeName>Doina</ForeName>                    <Initials>D</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4703-7009</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Torres-Cabala</LastName>                    <ForeName>Carlos A</ForeName>                    <Initials>CA</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7422-0661</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Curry</LastName>                    <ForeName>Jonathan L</ForeName>                    <Initials>JL</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0630-6222</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tetzlaff</LastName>                    <ForeName>Michael T</ForeName>                    <Initials>MT</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7899-4138</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aung</LastName>                    <ForeName>Phyu P</ForeName>                    <Initials>PP</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nagarajan</LastName>                    <ForeName>Priyadharsini</ForeName>                    <Initials>P</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5346-2669</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Suster</LastName>                    <ForeName>Saul</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Prieto</LastName>                    <ForeName>Victor G</ForeName>                    <Initials>VG</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>24</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Cutan Pathol</MedlineTA>            <NlmUniqueID>0425124</NlmUniqueID>            <ISSNLinking>0303-6987</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">angiosarcoma</Keyword>            <Keyword MajorTopicYN="N">atypical vascular lesion</Keyword>            <Keyword MajorTopicYN="N">breast</Keyword>            <Keyword MajorTopicYN="N">post-radiation vascular lesions</Keyword>            <Keyword MajorTopicYN="N">skin</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30251277</ArticleId>            <ArticleId IdType="doi">10.1111/cup.13363</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>